Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Moyang Bio

Request full access

Synthetic biology for medical aesthetic products

Minhang District, ChinaFounded 2018Biotech & Life Sciences

About Moyang Bio

Shanghai Moyom Biotechnology Co., Ltd. is a Chinese research, development, and production enterprise focused on the medical aesthetics market. The company is dedicated to creating a material platform based on calcium microspheres and CMC (carboxymethyl cellulose) gels. Its product pipeline includes superficial anti-aging skin products, with its core product, Moyan Microcrystalline, undergoing registration and evaluation as a national Class III medical device in China. Moyom Biotechnology operates in the high-tech enterprise sector, specializing in R&D, production, sales, and consulting services within the medical aesthetics field.

The company aims to enhance its internal research capabilities to provide high-standard products and professional technical services, positioning medical aesthetics within the essence of medicine.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
20.0/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotechnology, Synthetic Biology, biomanufacturing, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Aug 2025 $28M $110M Huagai Capital · BlueRun Ventures ↗
SERIES BEquity / VC Nov 2024 $0 — Undisclosed —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Moyang Bio in the Minhang District ecosystem

Live from Dealroom

The Moyang Bio office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later2 investors entered at this stage

  • Huagai Capital
  • BlueRun Ventures

Other known investors3 additional known investors

  • BioTrack Capital
  • Jinding Capital
  • Lanchi Ventures
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Minhang District HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Moyang Bio on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Moyang Bio’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.